178 related articles for article (PubMed ID: 23251663)
1. A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.
Wei R; Yang C; Zeng M; Terry F; Zhu K; Yang C; Altmeyer R; Martin W; De Groot AS; Leng Q
PLoS One; 2012; 7(12):e51957. PubMed ID: 23251663
[TBL] [Abstract][Full Text] [Related]
2. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
Maje Bello A; Chaimongkolnukul K; Poomputsa K; Mekvichitsaeng P; Maprang Roshorm Y
Vaccine; 2024 Jun; 42(17):3733-3743. PubMed ID: 38705805
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide linear B-cell epitopes of enterovirus 71 in a hand, foot and mouth disease (HFMD) population.
Zhang H; Song Z; Yu H; Zhang X; Xu S; Li Z; Li J; Xu H; Yuan Z; Ma H; Yi Z; Hu Y
J Clin Virol; 2018 Aug; 105():41-48. PubMed ID: 29886372
[TBL] [Abstract][Full Text] [Related]
5. Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls.
Dang S; Gao N; Li Y; Li M; Wang X; Jia X; Zhai S; Zhang X; Liu J; Deng H; Dong T
Immunology; 2014 May; 142(1):89-100. PubMed ID: 24329688
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of platelets on the severity of hand, foot, and mouth disease infected with enterovirus 71.
Li Q; Wang Y; Xue W; Bian Z; Gao Y; Zeng Y; Tang L; Tang T; Tian Y; Guo W
Pediatr Res; 2021 Mar; 89(4):814-822. PubMed ID: 32516798
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.
Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX
Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925
[TBL] [Abstract][Full Text] [Related]
9. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
10. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
11. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
[TBL] [Abstract][Full Text] [Related]
12. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
13. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.
Ding Y; Chen X; Qian B; Wu G; He T; Feng J; Gao C; Wang L; Wang J; Li X; Cao M; Peng H; Zhao C; Pan W
Sci Rep; 2015 May; 5():10636. PubMed ID: 26023863
[TBL] [Abstract][Full Text] [Related]
17. Enterovirus 71 vaccine: close but still far.
Zhang D; Lu J; Lu J
Int J Infect Dis; 2010 Sep; 14(9):e739-43. PubMed ID: 20400350
[TBL] [Abstract][Full Text] [Related]
18. Replication and cytokine profiles of different subgenotypes of enterovirus 71 isolated from Thai patients in peripheral blood mononuclear cells.
Wongsa A; Noulsri E; Phawong C; Puthavathana P; Tassaneetrithep B
Microb Pathog; 2019 Jul; 132():215-221. PubMed ID: 31075431
[TBL] [Abstract][Full Text] [Related]
19. Challenges to licensure of enterovirus 71 vaccines.
Lee MS; Tseng FC; Wang JR; Chi CY; Chong P; Su IJ
PLoS Negl Trop Dis; 2012; 6(8):e1737. PubMed ID: 22953003
[TBL] [Abstract][Full Text] [Related]
20. Enterovirus-Specific Anti-peptide Antibodies.
Poh CL; Kirk K; Chua HN; Grollo L
Methods Mol Biol; 2015; 1348():341-50. PubMed ID: 26424285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
